ISMAEL BUÑO BORDE-rekin lankidetzan egindako argitalpenak (5)

2021

  1. Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma

    Cancer Medicine, Vol. 10, Núm. 21, pp. 7585-7592

2017

  1. Transient hemolysis due to anti-D and anti-A1 produced by engrafted donor's lymphocytes after allogeneic unmanipulated haploidentical hematopoietic stem cell transplantation

    Transfusion, Vol. 57, Núm. 10, pp. 2355-2358

2016

  1. Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience

    Bone Marrow Transplantation, Vol. 51, Núm. 10, pp. 1307-1312

  2. Inhibitory killer cell immunoglobulin-like receptor (iKIR) mismatches improve survival after T-cell-repleted haploidentical transplantation

    European Journal of Haematology, Vol. 96, Núm. 5, pp. 483-491

2014

  1. Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation

    European Journal of Haematology, Vol. 93, Núm. 3, pp. 239-246